Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ImmuVen
company
About
ImmuVen develops drugs to treat infectious diseases, cancer, and autoimmune disorders.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.68M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ImmuVenis is a biotechnology company with novel technology to discover and develop new biotherapeutics to treat infectious disease, cancer and autoimmune disorders
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.68M
ImmuVen has raised a total of
$1.68M
in funding over 2 rounds. Their latest funding was raised on
May 1, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 1, 2012 | Grant | $1.68M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ImmuVen is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
